Physician profile
Matthew Reiss
NPI 1407096944
$10,005.08
in general payments reported to CMS, 2019-2025
17 companies · $1,582 in 2025
The $1,582 reported for 2025 was more than what 81% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $543 · 2020: $69.09 · 2021: $35.42 · 2022: $177 · 2023: $377 · 2024: $7,221 · 2025: $1,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,663 · Food and Beverage: $1,816 · Travel and Lodging: $701.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,662.50 |
| Food and Beverage | $1,816.38 |
| Travel and Lodging | $701.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $7,629.63 | 2019-2025 | Novosorb Btm |
| Janssen Scientific Affairs, LLC | $662.50 | 2025 | Rybrevant |
| Acera Surgical, INC. | $515.31 | 2019-2025 | Restrata Wound Matrix |
| Smith+Nephew, INC. | $365.59 | 2019-2025 | Collagenase Santyl, Acticoat 4" X 4", Versajet |
| Urgo Medical North America, LLC | $176.41 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Urgoclean Ag |
| Aroa Biosurgery Incorporated | $146.69 | 2023 | |
| Kerecis Limited | $121.85 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Avita Medical Americas, LLC | $61.32 | 2019-2020 | |
| Mimedx Group, INC. | $59.04 | 2024 | |
| Tactile Systems Technology INC | $57.06 | 2025 | Flexitouch Plus, Nimbl |
| Integra Lifesciences Corporation | $45.97 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Organogenesis INC. | $35.42 | 2021 | |
| Biotissue Holdings INC. | $34.43 | 2025 | |
| Medline Industries LP | $33.70 | 2022 | |
| Polarityte, INC. | $25.77 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $19.46 | 2023 | Nuzyra |
| Vericel Corporation | $14.93 | 2023 | Nexobrid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Reiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.